Literature DB >> 29447811

Sensorineural and conductive hearing loss in infants diagnosed in the program of universal newborn hearing screening.

Katarzyna Wroblewska-Seniuk1, Piotr Dabrowski2, Grazyna Greczka2, Katarzyna Szabatowska3, Agata Glowacka3, Witold Szyfter2, Jan Mazela4.   

Abstract

OBJECTIVE: The aim of this study was to analyze infants diagnosed with sensorineural or conductive hearing deficit and to identify risk factors associated with these defects.
MATERIAL AND METHODS: A retrospective analysis of infants diagnosed with hearing deficit based on the database of the universal newborn hearing screening program and medical records of the patients.
RESULTS: 27 935 infants were covered by the universal neonatal hearing screening program. 109 (0.39%) were diagnosed with hearing deficit and referred for treatment and rehabilitation. 56 (51.4%) children were diagnosed with conductive, 38 (34.9%) with sensorineural and 15 (13.8%) with mixed type of hearing deficit. Children with sensorineural hearing deficit more frequently suffered from hyperbilirubinemia (p < 0.05), while infants with conductive hearing loss were more frequently diagnosed with isolated craniofacial anomalies (p < 0.05). The prevalence of other risk factors did not differ between the groups. Sensorineural hearing deficit occurred almost 3 times more often bilaterally than unilaterally (p < 0.05). In other types of hearing deficit, the difference was not significant. In children with conductive and mixed type of hearing loss the impairment was mainly mild while among those with sensorineural hearing deficit in almost 45% it was severe and profound (p < 0.05). When analyzing the consistency between hearing screening test by means of otoacoustic emissions and the final diagnosis of hearing deficit we found that the highest agreement rate was observed in children with sensorineural hearing loss (p < 0.01).
CONCLUSIONS: The prevalence of most risk factors of hearing deficit was similar in children with sensorineural, conductive and mixed type of hearing loss, only hyperbilirubinemia seemed to predispose to sensorineural hearing deficit and isolated craniofacial malformations seemed to be associated with conductive hearing loss. Sensorineural hearing deficit usually occurred bilaterally and was severe or profound, while conductive and mixed type of hearing deficit were most often of mild degree. Most children with the final diagnosis of sensorineural hearing deficit had positive result of hearing screening by means of otoacoustic emissions.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conductive hearing loss; Hearing deficit; Newborn; Screening; Sensorineural hearing loss

Mesh:

Year:  2017        PMID: 29447811     DOI: 10.1016/j.ijporl.2017.12.007

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  4 in total

1.  Universal newborn hearing screening with automated auditory brainstem response (AABR) in Hungary: 5-year experience in diagnostics and influence on the early intervention.

Authors:  Anita Gáborján; Gábor Katona; Miklós Szabó; Béla Muzsik; Marianna Küstel; Mihály Horváth; László Tamás
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-29       Impact factor: 3.236

2.  Neonatal Screening for Congenital Hearing Loss in the North of Jordan; Findings and Implications.

Authors:  Amjad Nuseir; Maha Zaitoun; Hasan Albalas; Malak Douglas; Yazan Kanaan; Ahmad AlOmari; Firas Alzoubi
Journal:  Int J Prev Med       Date:  2021-12-01

3.  Global prevalence of long-term neurodevelopmental impairment following extremely preterm birth: a systematic literature review.

Authors:  Sujata P Sarda; Grammati Sarri; Csaba Siffel
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

4.  Audiological follow-up of children with congenital Zika syndrome.

Authors:  Lilian F Muniz; Rebeka J F Maciel; Danielle S Ramos; Kátia M G Albuquerque; Ângela C Leão; Vanessa Van Der Linden; Enny S Paixão; Elizabeth B Brickley; Marli T Cordeiro; Gabriella G S Leitão; Silvio S Caldas; Mariana C Leal
Journal:  Heliyon       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.